FR3046353B1 - Extrait de cassia alata contre la peau seche a tendance atopique - Google Patents

Extrait de cassia alata contre la peau seche a tendance atopique Download PDF

Info

Publication number
FR3046353B1
FR3046353B1 FR1563499A FR1563499A FR3046353B1 FR 3046353 B1 FR3046353 B1 FR 3046353B1 FR 1563499 A FR1563499 A FR 1563499A FR 1563499 A FR1563499 A FR 1563499A FR 3046353 B1 FR3046353 B1 FR 3046353B1
Authority
FR
France
Prior art keywords
atopic
trend
cassia alata
dry skin
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1563499A
Other languages
English (en)
Other versions
FR3046353A1 (fr
Inventor
Agnes Ducrocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Teane
Original Assignee
Laboratoires Teane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Teane filed Critical Laboratoires Teane
Priority to FR1563499A priority Critical patent/FR3046353B1/fr
Publication of FR3046353A1 publication Critical patent/FR3046353A1/fr
Application granted granted Critical
Publication of FR3046353B1 publication Critical patent/FR3046353B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne l'utilisation cosmétique d'une quantité efficace d'un extrait de Cassia alata, ou d'une composition le contenant, comme agent pour prévenir une diminution et/ou améliorer la fonction barrière de la peau. Elle concerne aussi un extrait de Cassia alata pour son utilisation topique dans le traitement préventif et/ou curatif de la peau très sèche, xérotique ou à tendance eczémateuse.
FR1563499A 2015-12-31 2015-12-31 Extrait de cassia alata contre la peau seche a tendance atopique Active FR3046353B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1563499A FR3046353B1 (fr) 2015-12-31 2015-12-31 Extrait de cassia alata contre la peau seche a tendance atopique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1563499 2015-12-31
FR1563499A FR3046353B1 (fr) 2015-12-31 2015-12-31 Extrait de cassia alata contre la peau seche a tendance atopique

Publications (2)

Publication Number Publication Date
FR3046353A1 FR3046353A1 (fr) 2017-07-07
FR3046353B1 true FR3046353B1 (fr) 2020-01-10

Family

ID=56101509

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1563499A Active FR3046353B1 (fr) 2015-12-31 2015-12-31 Extrait de cassia alata contre la peau seche a tendance atopique

Country Status (1)

Country Link
FR (1) FR3046353B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111518070B (zh) * 2020-06-08 2022-12-09 云南民族大学 一种翅荚决明中抗轮状病毒的化合物、制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4143223B2 (ja) * 1999-07-30 2008-09-03 一丸ファルコス株式会社 保湿性植物抽出物を含有する化粧料組成物
JP2001081021A (ja) * 1999-09-09 2001-03-27 Ichimaru Pharcos Co Ltd 化粧料組成物
FR2813195B1 (fr) * 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
EP1607098A1 (fr) * 2004-05-28 2005-12-21 Cognis France, S.A.S. Utilisation cosmétique d'un agent actif augmentant l'expression du gène Gadd45
FR2946880B1 (fr) * 2009-06-22 2011-07-15 Oreal Composition contenant un extrait de bacterie filamenteuse et procede de traitement cosmetique des signes du vieillissement

Also Published As

Publication number Publication date
FR3046353A1 (fr) 2017-07-07

Similar Documents

Publication Publication Date Title
PH12017502092A1 (en) Topical pharmaceutical compositions
MA40454B1 (fr) Gamma-dicétones pour le traitement et la prévention des rides et du vieillissement de la peau
MA44549A1 (fr) Agents immunorègulateurs
BR112016021011A8 (pt) composição tópica e usos de um composto
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
MX2015003229A (es) Composiciones que comprenden mezclas de alcanos semifluorados.
MA47356A1 (fr) Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases
BR112014024793A2 (pt) método de inibição da ativação do complemento dependente de masp-3, e, composição farmacêutica.
MX2017015012A (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
PH12018500184A1 (en) Formulation for soft anticholinergic analogs
PH12019500142A1 (en) Formulation for soft anticholinergic analogs
FR2968211B1 (fr) Utilisation d'extrait de levure du genre saccharomyces pour ameliorer l'eclat du teint et composition comprenant au moins cet extrait et un agent depigmentant
FR3046353B1 (fr) Extrait de cassia alata contre la peau seche a tendance atopique
FR3088542B1 (fr) Composition cicatrisante comprenant une eau électrolysée
MX2018000538A (es) Composicion antimicrobiana.
PH12017502145A1 (en) Composition and uses thereof
FR3065009B1 (fr) Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
EP3417869A4 (fr) Composition contenant un extrait de phragmitis rhizoma en tant que principe actif servant à prévenir, améliorer ou traiter une maladie attribuée à un effet secondaire d'agent anticancéreux
FR3034670B1 (fr) Nouvelle utilisation du facteur von willebrand
FR3065373B1 (fr) Composition comprenant un extrait de cognassier pour le traitement du prurit et de la dermatite atopique
EA201992547A1 (ru) Композиции для местного ухода за кожей
FR3067938B1 (fr) Utilisation d'une composition cosmetique et/ou dermatologique contre les effets induits par la lumiere bleue
BR112015021448A2 (pt) kits e métodos para o tratamento de câncer utilizando peptídeos gliadina
MX358072B (es) Composiciones tópicas que comprenden diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que involucran un aumento del dolor.
FR3065372B1 (fr) Composition comprenant de la carboxy methyl naringenine chalcone pour le traitement du prurit et de la dermatite atopique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170707

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9